2020
DOI: 10.1101/2020.12.18.423449
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Apoptosis-resistance of senescent cells is an intrinsic barrier for senolysis induced by cardiac glycosides

Abstract: Targeted elimination of senescent cells – senolysis – is one of the core trends in the anti-aging therapy. Cardiac glycosides were recently proved to be a broad-spectrum senolytics. Here we tested senolytic properties of cardiac glycosides towards human mesenchymal stem cells (hMSCs). Cardiac glycosides had no senolytic ability towards senescent hMSCs of various origins. Using biological and bioinformatic approaches we compared senescence development in ‘cardiac glycosides–sensitive’ A549 and ‘–insensitive’ hM… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 66 publications
(29 reference statements)
1
2
0
Order By: Relevance
“…Cardiac glycosides do induce apoptotic death in human embryonic stem cells (hESCs) but not in hESCderived mesenchymal stem cells and human bone marrow mesenchymal stem cells (hBMMSCs) 66 . As reported recently and also shown in our study, cardiac glycosides do not induce apoptosis in both hMESCs and their senescent partners 105 . Obviously, the high resistance of hMESCs to cardiac glycosides is provided by a highly expressed anti-apoptotic program in these cells 32,64,65,106,107 .…”
Section: Discussionsupporting
confidence: 90%
“…Cardiac glycosides do induce apoptotic death in human embryonic stem cells (hESCs) but not in hESCderived mesenchymal stem cells and human bone marrow mesenchymal stem cells (hBMMSCs) 66 . As reported recently and also shown in our study, cardiac glycosides do not induce apoptosis in both hMESCs and their senescent partners 105 . Obviously, the high resistance of hMESCs to cardiac glycosides is provided by a highly expressed anti-apoptotic program in these cells 32,64,65,106,107 .…”
Section: Discussionsupporting
confidence: 90%
“…The correct response of ESCs to the increasing levels of steroid hormones during the second phase of the menstrual cycle resulting in decidual transformation of endometrial tissue marks WOI (Deryabin et al, 2020). During this limited time period endometrium becomes receptive and enables further implantation.…”
Section: Resultsmentioning
confidence: 99%
“…While low doses of cardioglycosides induced the selective senolysis of BRAF-V600E-induced senescent fibroblasts through signal transduction and autophagy inhibition [34], their action in other senescence models was rather attributed to disturbance of membrane potential [33,35]. Interestingly, they proved inefficient in senescent human mesenchymal stem cells that have upregulated processes for potassium import but could nevertheless be primed for senolysis through the inhibition of anti-apoptotic MCL-1 [124]. On the other hand, the authors noted that etoposide-induced senescent A549 cells exhibited a decreased capacity to restore intracellular potassium levels, the drop of which is an early event in apoptosis, and as such made them less resilient in the face of stress, contradicting the notion of senescence-associated apoptosis resistance.…”
Section: Class III Senolytics: Further Disturbing Cellular Homeostati...mentioning
confidence: 99%